Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service

Pharmacotherapy

Volumn 26, Issue 2, 2006, Pages 248-253

  McCord, Amie D ^a  

^a MIDWESTERN UNIVERSITY   (United States)

Author keywords

Clinical pharmacy; Diabetes mellitus; Disease management; Drug therapy management

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDIABETIC AGENT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CHOLESTEROL BLOOD LEVEL; CLINICAL PHARMACY; DIABETES MELLITUS; FEMALE; HUMAN; INFLUENZA VACCINATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MANAGED CARE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; RETINA EXAMINATION; TRIACYLGLYCEROL BLOOD LEVEL; UNITED KINGDOM;

AGED; BLOOD PRESSURE; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; PATIENT CARE MANAGEMENT; PATIENT EDUCATION; PHARMACEUTICAL SERVICES; PHARMACISTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 32044466037     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.26.2.248     Document Type: Article

References (28)

1. Department of Health and Human Services. Centers for Disease Control diabetes fact sheet, 2003. Available from http://www.cdc.gov/diabetes/pubs/pdf/ ndfs_2003.pdf. Accessed March 22, 2005.
2. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329(14):977-86.
3. UKPDS Group. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes. Lancet 1998;352:854-65.
4. UKPDS Group. Intensive blood-glucose control with sulfonylureas or insulin compared to conventional treatment and risk comparison in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
5. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
6. UKPDS Group. Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. BMJ 2000;321:405-12.
7. Haffner S, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in patients with type 2 diabetes and in nondiabetic patients with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
8. Hansson L, Zanchetti A, Carruthers S, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial: HOT study group. Lancet 1998;351:1755-62.
9. Curb J, Pressel S, Cutler J, et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension: systolic hypertension in the elderly program cooperative research group. JAMA 1996;276:1886-92.
10. HOPE Study Investigators. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Lancet 2000;355:253-9.
11. Pyorala K, Pedersen T, Kjekshus J, Faergeman O, Olsson A, Thorgeirsson G. Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian simvastatin survival study (4S). Diabetes Care 1997;20:614-20.
12. Goldberg R, Mellies M, Sacks F, et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. Circulation 1998;98:2513-19.
13. Rubins H, Robins S, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999;341:410-18.
14. Turner RC, Millns H, Neil H, et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23). BMJ 1998;316:823-8.
15. American Diabetes Association. ADA clinical practice recommendations. Diabetes Care 2002;25:S140-7.
16. Marrero DG, Moore PS, Langefeld CD, et al. The treatment of patients with insulin-requiring DM by primary care physicians. J Commun Health 1991;16:259-67.
17. Jacques CHM, Jones RL, Houts P, et al. Reported practice behaviors for medical care of patients with DM by primary care physicians in Pennsylvania. Diabetes Care 1991;14:712-71.
18. Anonymous. Survey of physician practice behaviors related to the treatment of people with diabetes mellitus: final report. Washington, DC: National Institute of Diabetes and Digestive and Kidney Diseases, 1990.
19. Tuttleman M, Lipsett L, Harris MI. Attitudes and behaviors of primary care physicians regarding tight control of blood glucose in IDDM patients. Diabetes Care 1993;16:765-72.
20. Beckles GL, Engelgau MM, Narayan KM, et al. Population-based assessment of the level of care among adults with diabetes in the US. Diabetes Care 1998;21:1432-8.
21. Clark C, Snyder J, Meek R, Stutz L, Parkin C. A systematic approach to risk stratification and intervention within a managed care environment improves diabetes outcomes and patient satisfaction. Diabetes Care 2001;24:1079-86.
22. Maljanian R, Grey N, Staff I, Cruz-Marino-Aponte M. Improved diabetes control through a provider-based disease management program. Dis Manage Health Outcomes 2002;10:1-8.
23. Deeb L, Pettijohn F, Shirah J, Freeman G. Interventions among primary care practitioners to improve care for preventable complications of diabetes. Diabetes Care 1988;11:275-80.
24. Norris S, Nichols P, Casperson C, et al. The effectiveness of disease and case management for people with diabetes: a systemic review. Am J Prev Med 2002;22(suppl 4):15-38.
25. Coast-Senior E, Kroner B, Kelley C, Trilli E. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann Pharmacother 1998;32:636-40.
26. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (ATPIII). JAMA 2001;285(19):2486-97.
27. Wagner E, Sandu N, Newton K, McCullloch D, Ramsey S, Grothaus L. Effect of improved glycemic control on health care costs and utilization. JAMA 2001;285:182-9.
28. Grundy S, Cleeman J, Merz C, et al. Implications of recent clinical trials for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004;110:227-39.